Navigation Links
New strategy developed to diagnose melanoma
Date:3/30/2009

A UCSF research team has developed a technique to distinguish benign moles from malignant melanomas by measuring differences in levels of genetic markers. Standard microscopic examinations of biopsied tissue can be ambiguous and somewhat subjective, the researchers say, and supplementing standard practice with the new technique is expected to help clarify difficult-to-diagnose cases.

In a large study of previously diagnosed cases, the new technique distinguished between benign, mole-like skin lesions and melanomas with a success rate higher than 90 percent. It also succeeded with most of the previously misdiagnosed cases, which were among the most difficult to distinguish.

This is the first large-scale study to demonstrate both the high diagnostic accuracy and practicality of a multi-biomarker approach to melanoma diagnosis, said Mohammed Kashani-Sabet, MD, professor of dermatology at UCSF and director of the Melanoma Center at the UCSF Helen Diller Family Comprehensive Cancer Center.

Kashani-Sabet is lead author on a paper reporting the new finding in the Proceedings of the National Academy of Sciences, which is scheduled for online publication the week of March 30, 2009. The paper also will appear in a future print issue of PNAS.

Melanoma is the deadliest form of skin cancer. It can spread to almost any organ of the body and is difficult to treat in its advanced stages. Progress in survival rates has been made principally through earlier diagnosis. The genomics-based approach combined with current diagnostic practice can aid earlier detection and contribute to more accurate assessment, report the UCSF scientists who developed the diagnostic tool.

The molecular diagnosis strategy is now being developed for clinical use by a diagnostics company.

To develop the diagnostic tool, the researchers first used a microarray a "gene chip" -- to identify about 1,000 human genes that were present at different levels in malignant melanomas compared to benign moles. They narrowed their study down to five genes that all showed higher levels of activity in melanomas than in moles and could be studied with standard antibody techniques.

Focusing on the proteins produced by the five genes, they stained the proteins with antibodies to assess the level of gene expression in mole and melanoma tissues. The new diagnostic technique distinguished moles from melanomas by differences in both the level and the pattern of activity of the five proteins.

To develop and test the diagnostic technique, the researchers examined levels of the five biomarkers in 693 previously diagnosed tissue samples. To ensure that the diagnosis based on tissue examination had been correct, all samples were reviewed by the study's pathologist. They analyzed the samples with the new procedure and found that the increased protein production by the melanomas compared with the moles was statistically significant, and thus a reliable diagnostic indicator. Unexpectedly, the proteins also showed different patterns of activity in the two types of tissue, yielding a second, even more discriminating diagnostic indicator.

"We hoped for clear diagnostic differences in the intensity of gene expression," Kashani-Sabet said. "We found what we had hoped for, but then we got a bonus. The pattern of protein activity from the top to the bottom of the tissue was strikingly different between the benign and the malignant tissue, providing an additional trait valuable for diagnosis."

Although some of the genes and their proteins were stronger indicators than others, the research team found that the combination of all five achieved the highest diagnostic accuracy. The multi-biomarker diagnostic correctly diagnosed 95 percent of the benign moles -- a measure known as specificity. The accuracy rate was 91 percent for diagnosing malignant melanomas the sensitivity rate. In addition, the strategy correctly diagnosed 75 percent of the most difficult cases, which had previously been misdiagnosed. The technique also accurately diagnosed other difficult-to-diagnose moles, known as dysplastic and Spitz nevi.

"We have a test that can help patients and help clinicians who treat melanoma," said Kashani-Sabet. "With this added diagnostic tool we can shed light on lesions that are difficult to classify and diagnose."


'/>"/>

Contact: Susan Cohen
scohen@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
Source:Eurekalert

Related medicine news :

1. North Texas LEAD Offers Unique Approach to Job Search Strategy
2. Single embryo transfer is the cheapest and most effective strategy for assisted reproduction
3. Licorice compound offers new cancer prevention strategy
4. MRSA study suggests strategy shift needed to develop effective therapeutics
5. New strategy to weaken traumatic memories
6. New York State health IT strategy may be model for the nation
7. LCA-Vision New Excimer Laser Strategy to Reduce Operating Expenses in Excess of $3 Million Annually
8. How to Increase Sales Margin 1 Percent to 10 Percent and Lower Your Risk by Building a Negotiation Strategy into Your Sales Process
9. LCA-Vision Reports Tangible Results from Business Strategy
10. New health reform strategy would insure everyone, improve health and slow spending growth
11. Health Care Workers Call on ARH Board Members to Meet, Develop Real Strategy to Deal With Hospitals Bottom Line
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... 2016 , ... The annual list showcases the 20 Most Promising SharePoint Solution ... dedication and commitment to the SharePoint ecosystem. A panel of experts and members of ... to recognize and promote technology entrepreneurship. , The survey was made at the ...
(Date:2/11/2016)... ... February 11, 2016 , ... Husted Kicking has completed ... CA, on February 6th & 7th, 2016 according to kicking coach Michael Husted. , ... invited to the NFL’s combine in Indianapolis,” says Husted. “The NFL uses a third ...
(Date:2/10/2016)... ... February 10, 2016 , ... President Obama’s ... Advantage organizations to deliver medical services via telehealth, estimated to generate more than ... for such language for many years. Although there is more to be ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... full-service health care communications company offering education, research and medical media, has ... and specialists working in infectious diseases. , As the all-inclusive resource for ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... Academy of Emergency Medicine , an emergency medicine professional association, to support the ... . , The American Academy of Emergency Medicine, or AAEM, seeks to empower ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... Transformational M&A achieved through NPS and Dyax acquisitions and ... M&A achieved through NPS and Dyax acquisitions and the announced ... achieved through NPS and Dyax acquisitions and the announced combination ... most robust pipeline in Shire , s history ... robust pipeline in Shire , s history   ...
(Date:2/11/2016)... --> --> ... report, titled "Sports Medicine Devices Market - Global Industry Analysis, ... to the report, the global sports medicine devices market is ... 2019, growing from a value of US$6.1 bn in 2012 ... --> The global sports medicine devices market is ...
(Date:2/11/2016)... , February 11, 2016 F ast ... answers at the ... world-leading provider of scientific, technical and medical information products and services, has ... evidence-based, peer reviewed clinical information via a mobile device. Elsevier designed the ... for Nursing. The new app is available in Android and ...
Breaking Medicine Technology: